Literature DB >> 2197138

Transgenic mouse models of type I diabetes.

M A Lipes1, G S Eisenbarth.   

Abstract

Transgenic mouse technology has gained recognition as an important tool for examining many fundamental biological questions in vivo. Recently, transgenic mouse techniques have been applied to the study of type I (insulin-dependent) diabetes. These studies have been particularly informative in elucidating 1) mechanisms whereby immune tolerance is maintained to antigens on rare specialized cells such as the pancreatic beta-cell, 2) disease susceptibility and resistance genes, and 3) potentially important immune effector mechanisms. In this article, we discuss these studies, their impact on understanding of the pathogenesis of type I diabetes, and the potential of the transgenic mouse approach for future research.

Entities:  

Mesh:

Year:  1990        PMID: 2197138     DOI: 10.2337/diab.39.8.879

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

Review 1.  Cellular basis of T-cell autoreactivity in autoimmune diseases.

Authors:  C Carnaud; J F Bach
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

2.  The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model.

Authors:  J L Ottesen; P Nilsson; J Jami; D Weilguny; M Dührkop; D Bucchini; S Havelund; J M Fogh
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

3.  Effect of T-cell receptor V beta-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice.

Authors:  T Taki; K Yokono; K Amano; N Hatamori; Y Hirao; Y Tominaga; S Maeda; M Kasuga
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.